Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Neurology
|
February 26, 2004
The clinical significance of diffusion-weighted MR imaging in infratentorial strokes
S T Engelter, S G Wetzel, E W Radue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 10, 2015
Fingolimod effect on brain volume loss independently contributes to its effect on disability
M P Sormani, N De Stefano, G Francis, et al.
Magma (New York, N.Y.)
|
June 1, 1996
Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors
I Mader, W Roser, G Hagberg, et al.
AJNR. American Journal of Neuroradiology
|
March 14, 2007
In vivo assessment and visualization of intracranial arterial hemodynamics with flow-sensitized 4D MR imaging at 3T
S Wetzel, S Meckel, A Frydrychowicz, et al.
European Radiology
|
April 18, 2002
Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms
W Wiesner, S G Wetzel, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 27, 2011
Prediction of long-term disability in multiple sclerosis
R Schlaeger, M D'Souza, C Schindler, et al.
Neurology
|
January 6, 2009
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study
P O'Connor, G Comi, X Montalban, et al.
AJNR. American Journal of Neuroradiology
|
May 15, 2007
MR angiography of dural arteriovenous fistulas: diagnosis and follow-up after treatment using a time-resolved 3D contrast-enhanced technique
S Meckel, M Maier, D San Millan Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
G Comi, P O'Connor, X Montalban, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 22, 2008
[Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]
M Sailer, F Fazekas, A Gass, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Neurology
|
February 26, 2004
The clinical significance of diffusion-weighted MR imaging in infratentorial strokes
S T Engelter, S G Wetzel, E W Radue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 10, 2015
Fingolimod effect on brain volume loss independently contributes to its effect on disability
M P Sormani, N De Stefano, G Francis, et al.
Magma (New York, N.Y.)
|
June 1, 1996
Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors
I Mader, W Roser, G Hagberg, et al.
AJNR. American Journal of Neuroradiology
|
March 14, 2007
In vivo assessment and visualization of intracranial arterial hemodynamics with flow-sensitized 4D MR imaging at 3T
S Wetzel, S Meckel, A Frydrychowicz, et al.
European Radiology
|
April 18, 2002
Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms
W Wiesner, S G Wetzel, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 27, 2011
Prediction of long-term disability in multiple sclerosis
R Schlaeger, M D'Souza, C Schindler, et al.
Neurology
|
January 6, 2009
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study
P O'Connor, G Comi, X Montalban, et al.
AJNR. American Journal of Neuroradiology
|
May 15, 2007
MR angiography of dural arteriovenous fistulas: diagnosis and follow-up after treatment using a time-resolved 3D contrast-enhanced technique
S Meckel, M Maier, D San Millan Ruiz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
G Comi, P O'Connor, X Montalban, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
October 22, 2008
[Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]
M Sailer, F Fazekas, A Gass, et al.
Page
of 8